Trial Profile
An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2024
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Enteris BioPharma
- 26 Oct 2022 According to an Enteris BioPharma Media Release, results from this trial were presented in an oral presentation at the American Society for Reproductive Medicine Scientific (ASRM) 2022 Congress & Expo.
- 26 Oct 2022 Results published in an Enteris BioPharma Media Release.
- 21 Mar 2022 Status changed from not yet recruiting to recruiting.